Market Cap | 521.26K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -357.03k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -3.00% |
Sales | 1.11M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -34.00% |
Dividend | N/A | Price/Book | 6.25 | EPS next 5Y | - | 52W High Chg | -62.00% |
Recommedations | - | Quick Ratio | 312.68 | Shares Outstanding | 17.06M | 52W Low Chg | 35.00% |
Insider Own | 5.10% | ROA | - | Shares Float | 8.27M | Beta | 3.51 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.35 |
Gross Margin | 10.12% | Profit Margin | -31.99% | Avg. Volume | 6,500 | Target Price | - |
Oper. Margin | 2.38% | Earnings Date | - | Volume | 1,800 | Change | 0.00% |
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.